Lectus Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Lectus Therapeutics General Information

Description

Operator of a drug discovery and development company intended to focus on next-generation ion channel modulators. The company offers ion-channel modulators for a range of illnesses including angina, asthma, epilepsy urinary bladder disorders and more.

Contact Information

Formerly Known As
Interaction Pharmaceuticals, FLEETNESS 327
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • PO Box 2299
  • Bristol BS99 5YG
  • England, United Kingdom
+44 0117
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Corporate Office
  • PO Box 2299
  • Bristol BS99 5YG
  • England, United Kingdom
+44 0117

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lectus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 22-Nov-2011 Completed Generating Revenue
5. Later Stage VC 05-Sep-2007 Completed Startup
4. Early Stage VC (Series A) 13-Feb-2006 Completed Startup
3. Early Stage VC 06-May-2004 Completed Startup
2. Seed Round 03-Nov-2003 Completed Startup
1. University Spin-Out 15-Oct-2002 Completed
To view Lectus Therapeutics’s complete valuation and funding history, request access »

Lectus Therapeutics Patents

Lectus Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0817576-D0 Calcium ion channel modulators & uses thereof Inactive 25-Sep-2008
GB-0814076-D0 Ion channel modulator combinations and uses thereof Inactive 01-Aug-2008
GB-0813403-D0 Potassium ion channel modulators & uses thereof Inactive 22-Jul-2008
AU-2009265292-A1 Calcium ion channel modulators and uses thereof Inactive 03-Jul-2008
CA-2729688-A1 Calcium ion channel modulators & uses thereof Inactive 03-Jul-2008 C07D491/056
To view Lectus Therapeutics’s complete patent history, request access »

Lectus Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lectus Therapeutics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Astellas Venture Management Corporate Venture Capital Minority
Questar Assessment Corporation Minority
Quester (Private Equity) Venture Capital Minority
Rockwood Strategic Hedge Fund Minority
Sofinnova Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Lectus Therapeutics Acquisitions (1)

Lectus Therapeutics’s most recent deal was a Merger/Acquisition with NeuroServe. The deal was made on 19-Apr-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NeuroServe 19-Apr-2006 Merger/Acquisition Other Healthcare Technology Systems
To view Lectus Therapeutics’s complete acquisitions history, request access »

Lectus Therapeutics FAQs

  • When was Lectus Therapeutics founded?

    Lectus Therapeutics was founded in 2002.

  • Where is Lectus Therapeutics headquartered?

    Lectus Therapeutics is headquartered in Bristol, United Kingdom.

  • What is the size of Lectus Therapeutics?

    Lectus Therapeutics has 4 total employees.

  • What industry is Lectus Therapeutics in?

    Lectus Therapeutics’s primary industry is Drug Discovery.

  • Is Lectus Therapeutics a private or public company?

    Lectus Therapeutics is a Private company.

  • What is Lectus Therapeutics’s current revenue?

    The current revenue for Lectus Therapeutics is .

  • How much funding has Lectus Therapeutics raised over time?

    Lectus Therapeutics has raised $14M.

  • Who are Lectus Therapeutics’s investors?

    Astellas Venture Management, Questar Assessment, Quester (Private Equity), Rockwood Strategic, and Sofinnova Partners are 5 of 7 investors who have invested in Lectus Therapeutics.

  • When was Lectus Therapeutics acquired?

    Lectus Therapeutics was acquired on 22-Nov-2011.

  • Who acquired Lectus Therapeutics?

    Lectus Therapeutics was acquired by UCB Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »